PATENT CLAIM ANALYSIS

Application Number: 15774622
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "007300"]

Abstract:
Co-agonists of the glucagon and GLP-1 receptors are described.

Claim (Index 19):
A method for treating a metabolic disease or disorder in a patient or individual comprising: administering to the patient or individual an effective amount of any one of the aforementioned compositions comprising a co-agonist peptide agonist and administering to the patient or individual an effective amount of a composition comprising an insulin or insulin analog to treat the metabolic disease or disorder in the patient or individual.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15519565', '15851963', '15248712', '15566338', '15852458']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7282273324117856
- 35 USC 102 Novelty (BERT): 0.5473975863511551
- Combined Prediction Score: 0.7101443578057226
- Mean Citation Score: 337.990672
- Max Citation Score: 390.14993
- Similarity Product: 318.449565486483

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test